Dana Elizabeth Honzel Angelos, DO | |
2200 Ne Professional Ct, Bend, OR 97701-6063 | |
(541) 389-6313 | |
Not Available |
Full Name | Dana Elizabeth Honzel Angelos |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2200 Ne Professional Ct, Bend, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942695028 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | PENDING (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dana Elizabeth Honzel Angelos, DO 2200 Ne Professional Ct, Bend, OR 97701-6063 Ph: (503) 929-4432 | Dana Elizabeth Honzel Angelos, DO 2200 Ne Professional Ct, Bend, OR 97701-6063 Ph: (541) 389-6313 |
News Archive
Barrett's esophagus (BE) patients who smoke tobacco are at a two-fold increased risk of developing esophageal cancer, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. BE patients who smoke also double their risk for developing advanced precancerous cells.
A molecule that can block the progress of Alzheimer's disease at a crucial stage in its development has been identified by researchers in a new study, raising the prospect that more such molecules may now be found.
A new study suggests that exposure to dust from homes with dogs may alter the immune response to allergens and other asthma triggers by affecting the composition of the gut microbiome-the community of microbes that naturally colonize the digestive tract.
Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.
› Verified 4 days ago
Benjamin Bruno Barsotti, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Dr. Brenna Kathryn Lewis, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Mr. Stacy C. Berube, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2200 Ne Professional Ct, Bend, OR 97701 Phone: 541-389-6313 Fax: 541-389-8760 | |
Dr. Kristi A Nix, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2084 Ne Professional Ct, Bend, OR 97701 Phone: 541-383-3005 Fax: 541-383-1883 | |
Scott Chambers Olson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-382-4321 | |
Erika Stephanie Beard-irvine, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 403 Ne Revere Ave, Bend, OR 97701 Phone: 541-241-6371 Fax: 877-991-7408 | |
Dr. Michelle R Mills, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 815 Sw Bond St, Bend, OR 97702 Phone: 541-382-4900 |